Tufton Capital Management Abbott Laboratories Transaction History

Tufton Capital Management

$532 Million
Q3 2024

A detailed history of Tufton Capital Management transactions in Abbott Laboratories stock. As of the latest transaction made, Tufton Capital Management holds 71,403 shares of ABT stock, worth $8.16 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares

71,403

Previous 74,173 3.73%

Holding current value

$8.16 Million

Previous $7.71 Million 5.62%

% of portfolio

1.53%

Previous 1.5%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$100.07 - $118.13 $277,193 - $327,220	-2,770 Reduced 3.73%	71,403 $8.14 Million
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $455,803 - $508,791	4,525 Added 6.5%	74,173 $7.71 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $23,875 - $26,369	-218 Reduced 0.31%	69,648 $7.92 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $78,014 - $95,496	-865 Reduced 1.22%	69,866 $7.69 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $36,301 - $43,555	-380 Reduced 0.53%	70,731 $6.85 Million
Q2 2023 Jul 28, 2023	SELL	$100.78 - $112.29 $203,273 - $226,488	-2,017 Reduced 2.76%	71,111 $7.75 Million
Q1 2023 Apr 19, 2023	BUY	$96.86 - $114.01 $35,741 - $42,069	369 Added 0.51%	73,128 $7.4 Million
Q4 2022 Jan 26, 2023	SELL	$95.06 - $111.52 $10,931 - $12,824	-115 Reduced 0.16%	72,759 $0
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $14,223 - $16,468	-147 Reduced 0.2%	72,874 $7.05 Million
Q2 2022 Jul 20, 2022	BUY	$102.07 - $123.37 $1,633 - $1,973	16 Added 0.02%	73,021 $7.93 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $1.22 Million - $1.49 Million	-10,708 Reduced 12.79%	73,005 $8.64 Million
Q4 2021 Jan 28, 2022	SELL	$115.53 - $141.46 $30,153 - $36,921	-261 Reduced 0.31%	83,713 $11.8 Million
Q3 2021 Oct 21, 2021	SELL	$116.66 - $129.06 $557,051 - $616,261	-4,775 Reduced 5.38%	83,974 $9.92 Million
Q2 2021 Jul 29, 2021	BUY	$105.79 - $124.53 $321,813 - $378,820	3,042 Added 3.55%	88,749 $10.3 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $345,458 - $407,002	-3,174 Reduced 3.57%	85,707 $10.3 Million
Q4 2020 Feb 01, 2021	SELL	$105.0 - $114.42 $24,570 - $26,774	-234 Reduced 0.26%	88,881 $9.73 Million
Q3 2020 Oct 23, 2020	SELL	$91.64 - $111.29 $82,934 - $100,717	-905 Reduced 1.01%	89,115 $9.7 Million
Q2 2020 Jul 27, 2020	SELL	$76.57 - $98.0 $79,173 - $101,332	-1,034 Reduced 1.14%	90,020 $8.23 Million
Q1 2020 Apr 23, 2020	BUY	$62.82 - $91.86 $54,276 - $79,367	864 Added 0.96%	91,054 $7.19 Million
Q4 2019 Jan 24, 2020	SELL	$78.51 - $87.4 $166,912 - $185,812	-2,126 Reduced 2.3%	90,190 $7.83 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $170,472 - $184,845	-2,083 Reduced 2.21%	92,316 $7.72 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $72,005 - $83,980	-988 Reduced 1.04%	94,399 $7.94 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $130,453 - $157,718	-1,970 Reduced 2.02%	95,387 $7.63 Million
Q4 2018 Jan 28, 2019	SELL	$65.56 - $74.27 $460,100 - $521,226	-7,018 Reduced 6.72%	97,357 $7.04 Million
Q3 2018 Oct 26, 2018	SELL	$60.81 - $73.36 $169,051 - $203,940	-2,780 Reduced 2.59%	104,375 $7.66 Million
Q2 2018 Aug 06, 2018	SELL	$57.57 - $63.54 $223,601 - $246,789	-3,884 Reduced 3.5%	107,155 $6.54 Million
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $125,088 - $141,427	-2,223 Reduced 1.96%	111,039 $6.65 Million
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $137,045 - $146,720	-2,553 Reduced 2.2%	113,262 $6.46 Million
Q3 2017 Oct 20, 2017	BUY	$48.06 - $53.64 $5.57 Million - $6.21 Million	115,815	115,815 $6.18 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tufton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Tufton Capital Management with notifications on news.

Account

Tufton Capital Management Abbott Laboratories Transaction History